From bedside to bench and back again: Research issues in animal models of human disease

Biological Research for Nursing

Volumn 8, Issue 1, 2006, Pages 78-88

  Tkacs, Nancy C ^a   Thompson, Hilaire J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Animal models; Diabetes complications; Hypoglycemia unawareness; Translational research

Indexed keywords

ANIMAL; ANIMAL EXPERIMENT; AUTONOMIC NEUROPATHY; AWARENESS; CLINICAL NURSING RESEARCH; DISEASE MODEL; ETHICS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW; RODENT; STANDARD;

ANIMAL EXPERIMENTATION; ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; AWARENESS; CLINICAL NURSING RESEARCH; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; HYPOGLYCEMIA; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RODENTIA;

EID: 33747187530     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800406289717     Document Type: Article

References (72)

1. Amiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987). Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. New England Journal of Medicine, 316, 1376-1383.
2. Briski, K. P. (1999). Intraventricular lactate infusion attenuates the transactivational effects of the glucose antimetabolite, 2-deoxy-D-glucose, on hypothalamic vasopressinergic neurons. Brain Research, 839, 341-345.
3. Cryer, P. E. (1994). Hypoglycemia: The limiting factor in the management of IDDM. Diabetes, 43, 1378-1389.
4. Cryer, P. E. (1997). Hypoglycemia: Pathophysiology, diagnosis, and treatment. Oxford, UK: Oxford University Press.
5. Cryer, P. E. (2001). Hypoglycemia-associated autonomic failure in diabetes. American Journal of Physiology Endocrinology and Metabolism, 281, E1115 - E1121.
6. Cryer, P. E. (2004). Diverse causes of hypoglycemia-associated autonomic failure in diabetes. New England Journal of Medicine, 350, 2272-2279.
7. Cryer, P. E. (2005). Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes, 54, 3592-3601.
8. Cryer, P. E., & Gerich, J. E. (1983). Relevance of glucose counterregulatory systems to patients with diabetes: Critical roles of glucagon and epinephrine. Diabetes Care, 6, 95-99.
9. Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993). Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. Journal of Clinical Investigation, 91, 819-828.
10. Dagogo-Jack, S. E., Fanelli, C. G., & Cryer, P. E. (1999). Durable reversal of hypoglycemia unawareness in type 1 diabetes (letter). Diabetes Care, 22, 866-867.
11. Dagogo-Jack, S. E., Rattarasarn, C., & Cryer, P. E. (1994). Reversal of hypoglycemia unawareness, but not defective glucose counterregulation in IDDM. Diabetes, 43, 1426-1434.
12. Davis, S. N., Mann, S., Galassetti, P., Neill, R. A., Tate, D., Ertl, A. C., et al. (2000). Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes, 49, 1897-1903.
13. Davis, S. N., Shavers, C., Costa, F., & Mosqueda-Garcia, R. (1996). Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. Journal of Clinical Investigation, 98, 680-691.
14. Davis, S. N., Shavers, C., Davis, B., & Costa, F. (1997). Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. Journal of Clinical Investigation, 100, 429-438.
15. Davis, S. N., Shavers, C., Mosqueda-Garcia, R., & Costa, F. (1997). Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes, 46, 1328-1335.
16. Dawkins, P. A., & Stockley, R. A. (2001). Animal models of chronic obstructive pulmonary disease. Thorax, 56, 972-977.
17. De Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998). Brain corticosteroid receptor balance in health and disease. Endocrine Reviews, 19, 269-301.
18. de Vries, M. G., Lawson, M. A., & Beverly, J. L. (2004). Dissociation of hypothalamic noradrenergic activity and sympathoadrenal responses to recurrent hypoglycemia. American Journal of Physiology Regulatory Integrative Comparative Physiology, 286, R910 - R915.
19. Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986.
20. Diabetes Control and Complications Trial Research Group. (1997). Hypoglycemia in the diabetes control and complications trial. Diabetes, 46, 271-286.
21. Evans, S. B., Wilkinson, C. W., Bentson, K., Gronbeck, P., Zavosh, A., & Figlewicz, D. P. (2001). PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat. American Journal of Physiology Regulatory Integrative Comparative Physiology, 281, R1426 - R1436.
22. Fanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., DiVincenzo, A., Modarelli, F., et al. (1993). Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes, 42, 1683-1689.
23. Feldman, R. S., Meyer, J. S., & Quenzer, L. F. (1997). Principles of neuropsychopharmocology. Sunderland, MA: Sinauer.
24. Flanagan, D. E., Keshavarz, T., Evans, M. L., Flanagan, S., Fan, X., Jacob, R. J., et al. (2003). Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia. Diabetes, 52, 605-613.
25. Gerich, J. E., Mokan, M., Veneman, T., Korytkowski, M., & Mitrakou, A. (1991). Hypoglycemia unawareness. Endocrine Reviews, 12, 356-371.
26. Giannopoulos, G., & Keichline, D. (1981). Species-related differences in steroid-binding specificity of glucocorticoid receptors in lung. Endocrinology, 108, 1414-1419.
27. Hall, J. E. (2001). The promise of translational physiology. American Journal of Physiology, 281, G1127 - G1128.
28. Hau, J., Andersen, L. L. I., Rye-Nielsen, B., & Poulsen, O. M. (1989). Laboratory animal models. Scandinavian Journal of Laboratory Animal Science, 16, 7-9.
29. Heller, S. R., & Cryer, P. E. (1991). Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes, 40, 223-226.
30. Inouye, K., Shum, K., Chan, O., Mathoo, J. M. R., Matthews, S. G., & Vranic, M. (2002). Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats. American Journal of Physiology, Endocrinology and Metabolism, 282, E1369 - E1379.
31. Jenck, F., Moreau, J., & Martin, J. R. (1995). Dorsal periaqueductal gray-induced aversion as stimulation of panic anxiety: Elements of face and predictive validity. Psychiatry Research, 57, 181-191.
32. Littman, B. H., & Williams, S. A. (2005). The ultimate model organism: progress in experimental medicine. Nature Reviews Drug Discovery, 4, 631-638.
33. Maran, A., Cranston, I., Lomas, J., Macdonald, I. A., & Amiel, S. A. (1994). Protection by lactate of cerebral function during hypoglycaemia. Lancet, 343, 16-20.
34. Maran, A., Crepaldi, C., Trupiani, S., Lucca, T., Jori, E., Macdonald, I. A., et al. (2000). Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type I diabetic subjects. Diabetologia, 43, 733-741.
35. Matyka, K., Wigg, L., Pramming, S., Stores, G., & Dunger, D. B. (1999). Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes. Archives of Diseases in Childhood, 81, 138-142.
36. McGregor, V. P., Banarer, S., & Cryer, P. E. (2002). Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. American Journal of Physiology, Endocrinology and Metabolism, 282, E770 - E777.
37. National Research Council (Committee to Revise the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources). (1996). Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
38. National Research Council (Committee on Guidelines for the Use of Animals in Neuroscience and Behavioral Research, Institute for Laboratory Animal Research). (2004). Guidelines for the care and use of mammals in neuroscience and behavioral research. Washington, DC: National Academy Press.
39. Ovalle, F., Fanelli, C. G., Paramore, D. S., Hershey, T., Craft, S., & Cryer, P. E. (1998). Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes, 47, 1472-1479.
40. Overmier, J. B. (1999). Elements of models/nature of models. In M. Haug & R. E. Whalen (Eds.), Animal models of human emotion and cognition. Washington, DC: American Psychological Association.
41. Page, G. G. (2004). The importance of animal research to nursing science. Nursing Outlook, 52, 102-107.
42. Paranjape, S. A., & Briski, K. P. (2004). Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation. Neuroscience, 130, 957-970.
43. Pober, J. S., Neuhauser, C. S., & Pober, J. M. (2001). Obstacles facing translational research in academic medical centers. The FASEB Journal, 15, 2303-2313.
44. Powell, A. M., Sherwin, R. S., & Shulman, G. I. (1993). Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Journal of Clinical Investigation, 92, 2667-2674.
45. Rabinovitch, A. (1994). Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes, 43, 613-621.
46. Raju, B., McGregor, V. P., & Cryer, P. E. (2003). Cortisol elevations comparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure. Diabetes, 52, 2083-2089.
47. Ramchandani, N., Cantey-Kiser, J. M., Alter, C. A., Brink, S. J., Yeager, S. D., Tamborlane, W. V., et al. (2000). Self-reported factors that affect glycemic control in college students with type 1 diabetes. Diabetes Educator, 26, 656-666.
48. Rattarasarn, C., Dagogo-Jack, S. E., Zachwieja, J. J., & Cryer, P. E. (1994). Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes, 43, 809-818.
49. Reach, G., Zerrouki, A., Leclercq, D., & d'Ivernois, J. F. (2005). Adjusting insulin doses: From knowledge to decision. Patient Education and Counseling, 56, 98-103.
50. Reul, J. M. H. M., & De Kloet, E. R. (1985). Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology, 117, 2505-2511.
51. Robinson, A. M., Parkin, H. M., MacDonald, I. A., & Tattersall, R. B. (1995). Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli. Clinical Science, 89, 359-366.
52. Sandoval, D. A., Ping, L., Neill, A. R., Morrey, S., & Davis, S. N. (2003). Cortisol acts through central mechanisms to blunt counterregulatory responses to hypoglycemia in conscious rats. Diabetes, 52, 2198-2204.
53. Shapiro, K. J. (1998). Animal models of psychology: Critique of science, ethics, policy. Seattle, WA: Hogrefe & Huber.
54. Shum, K., Inouye, K., Chan, O., Mathoo, J., Bilinski, D., Matthews, S. G., et al. (2001). Effects of antecedent hypoglycemia, hyperinsulinemia, and excess corticosterone on hypoglycemic counterregulation. American Journal of Physiology Endocrinology and Metabolism, 281, E455 - E465.
55. Sivitz, W. I., Herlein, J. A., Morgan, D. A., Fink, B. D., Phillips, B. G., & Haynes, W. G. (2001). Effect of acute and antecedent hypoglycemia on sympathetic neural activity and catecholamine responsiveness in normal rats. Diabetes, 50, 1119-1125.
56. Sutanto, W., & De Kloet, E. R. (1987). Species-specificity of corticosteroid receptors in hamster and rat brains. Endocrinology, 121, 1405-1411.
57. Svendsen, P., & Gottrup, F. (1998). Comparative biology of animals and man in surgical research. In B. Jeppsson (Ed.), Animal modeling in surgical research. Sydney, Australia: Harwood Academic.
58. Swinyard, A. E., & Castellion, A. W. (1966). Anticonvulsant properties of some benzodiazepines. Journal of Pharmacology and Experimental Therapeutics, 151, 369-375.
59. Thompson, H. J., Lifshitz, J., Marklund, N., Graham, D. G., Hovda, D. A., Grady, M. S., et al. (2005). Lateral fluid percussion: A 15 year review and evaluation. Journal of Neurotrauma, 22, 42-75.
60. Tkacs, N. C., Dunn-Meynell, A. A., & Levin, B. E. (2000). Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes, 49, 820-826.
61. Tkacs, N. C., Pan, Y., Raghupathi, R., Dunn-Meynell, A. A., & Levin, B. E. (2005). Cortical fluoro-jade staining and blunted adrenomedullary response to hypoglycemia after noncoma hypoglycemia in rats. Journal of Cerebral Blood Flow and Metabolism, 25, 1645-1655.
62. Treit, D. (1985). Animal models for the study of anti-anxiety agents: A review. Neuroscience and Biobehavioral Reviews, 9, 203-222.
63. United Kingdom Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
64. Vahl, T. P., Ulrich-Lai, Y. M., Ostrander, M. M., Dolgas, C. M., Elfers, E. E., Seeley, R. J., et al. (2005). Comparative analysis of ACTH and corticosterone sampling methods in rats. American Journal of Physiology, Endocrinology and Metabolism, 289, 823-828.
65. Veneman, T., Mitrakou, A., Mokan, M., Cryer, P., & Gerich, J. (1994). Effect of hyperketonemia and hyperlacticacidemi on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes, 43, 1311-1317.
66. Widom, B., & Simonson, D. C. (1992). Intermittent hypoglycemia impairs glucose counterregulation. Diabetes, 41, 1597-1602.
67. Willner, P. (1984). The validity of animal models of depression. Psychopharmacology, 83, 1-16.
68. Willner, P. (1990). Animal models of depression: An overview. Pharmacology and Therapeutics, 45, 425-455.
69. Willner, P. (1997). Validity, reliability, and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology, 134, 319-329.
70. Yamada, K. A., Rensing, N., Izumi, Y., De Erausquin, G. A., Gazit, V., Dorsey, D. A., et al. (2004). Repetitive hypoglycemia in young rats impairs hippocampal long-term potentiation. Pediatric Research, 55, 372-379.
71. Yamada, K. A., Rensing, N., & Thio, L. L. (2005). Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neuroscience Letters, 385, 210-214.
72. Yu, L., Romero, D. G., Gomez-Sanchez, C. E., & Gomez-Sanchez, E. P. (2002). Steroidogenic enzyme gene expression in the human brain. Molecular and Cellular Endocrinology, 190, 9-17.